Distinct behavior of mutant triosephosphate isomerase in hemolysate and in isolated form: Molecular basis of enzyme deficiency

Blood

Volumn 98, Issue 10, 2001, Pages 3106-3112

  Orosz, Ferenc ^a,b,c,d   Oláh, Judit ^a,b,c,d   Alvarez, Marco ^a,b,c,d   Keserü, György M ^a,b,c,d   Szabó, Beáta ^a,b,c,d   Wágner, Gábor ^a,b,c,d   Kovári, Zoltán ^a,b,c,d   Horányi, Margit ^a,b,c,d   Baróti, Klára ^a,b,c,d   Martial, Joseph A ^a,b,c,d   Hollán, Susan ^a,b,c,d   Ovádi, Judit ^a,b,c,d  

^a INSTITUTE OF EXPERIMENTAL MEDICINE   (Hungary)

^b GEDEON RICHTER LTD   (Hungary)

^c Institute of Chemistry   (Belgium)

^d UNIVERSITY OF LIÈGE   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

TRIOSEPHOSPHATE ISOMERASE;

ARTICLE; BINDING AFFINITY; BRAIN CELL; CELL VACUOLE; CLINICAL ARTICLE; CODON; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME BINDING; ENZYME DEFICIENCY; ENZYME ISOLATION; FEMALE; GENE MUTATION; GENETIC RECOMBINATION; GERM LINE; HEMOLYSATE; HETEROZYGOTE; HOMOZYGOSITY; HUMAN; HUMAN CELL; MALE; MICROTUBULE; MISSENSE MUTATION; PRIORITY JOURNAL; RACE; STOP CODON; THERMODYNAMICS; WILD TYPE;

EID: 0035892130     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.V98.10.3106     Document Type: Article

References (30)

1. Lu HS, Yuan PM , Gracy RW. Primary structure of human triosephosphate isomerase. J Biol Chem. 1984;259:11958-11968.
2. Mande SC, Mainfroid V, Kalk KH, Goraj K, Martial JA, Hol WGJ. Crystal structure of recombinant human triosephosphate isomerase at 2.8 Å resolution. Triosephosphate isomerase-related human genetic disorders and comparison with the trypanosomal enzyme. Protein Sci. 1994;3:810-821.
3. Tanaka KR, Zerez CR. Red cell enzymopathies of the glycolytic pathway. Semin Hematol. 1990;27:165-185.
4. Schneider AS. Triosephosphate isomerase deficiency: historical perspectives and molecular aspects. Baillieres Best Pract Res Clin Haematol. 2000;13:119-140.
5. Hollán S, Fujii H, Hirono A, Hirono K, Karro H, et al. Hereditary triosephosphate isomerase (TPI) deficiency: two severely affected brothers one with and one without neurological symptoms. Hum Genet. 1993;92:486-490.
6. Chang M-L, Artymiuk PJ, Wu X, Hollán S, Lammi A, Maquat LE. Human triosephosphate isomerase deficiency resulting from mutation of Phe-240. Am J Hum Genet. 1993;52:1260-1269.
7. Valentin C, Cohen-Solal M, Maquat L, Horányi M, Inselt-Kovács M, Hollán S. Identical germ-line mutations in the triosephosphate isomerase alleles of two brothers associated with distinct clinical phenotypes. C R Acad Sci III. 2000;323:245-250.
8. Orosz F, Wágner G, Liliom K, Kovács J, Baróti K, et al. Enhanced association of mutant triosephosphate isomerase to red cell membranes and to brain microtubules. Proc Natl Acad Sci U S A. 2000;97:1026-1031.
9. Arya R, Lalloz MRA, Nicolaides KH, Bellingham AJ, Layton DM. Prenatal diagnosis of triosephosphate isomerase deficiency. Blood. 1996;87:4507-4509.
10. Ationu A, Humphries A, Lalloz MRA, Arya R, Wild B, et al. Reversal of metabolic block in glycolysis by enzyme replacement in triosephosphate isomerase-deficient cells. Blood. 1999;94:3193-3198.
11. Na CN, Timasheff SN. Interaction of vinblastine with calf brain tubulin: multiple equilibria. Biochemistry. 1986;25:6214-6222.
12. Sarkadi B, Szász I, Gárdos G. Characteristics and regulation of active calcium transport in inside-out red cell membrane vesicles. Biochim Biophys Acta. 1980;598:326-338.
13. Hollán S, Magócsi M, Fodor E, Horányi M, Harsá-nyi V, Farkas T. Search for the pathogenesis of the differing phenotype in two compound heterozygote Hungarian brothers with the same genotypic triosephosphate isomerase deficiency. Proc Natl Acad Sci U S A. 1997;94:10362-10366.
14. Orosz F, Vértessy B, Hollán S, Horányi M, Ovádi J. Triosephosphate isomerase deficiency: predictions and facts. J Theor Biol. 1996;182:437-447.
15. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976;72:248-254.
16. Klinkenberg M. Nicotinamide-adenine dinucleotides (NAD, NADP, NADH, NADPH). Spectrophotometric and fluorometric methods. In: Bergmeyer HU, ed. Methods of Enzymatic Analysis. Weinheim, Germany: Verlag Chemie; 1974:2045-2059.
17. Beutler E, Blume KG, Kaplan JC, Löhr GW, Ramot B, Valentine WN. International Committee for Standardization in Haematology: recommended methods for red-cell enzyme analysis. Br J Haematol. 1977;35:331-340.
18. Chen Y-H, Yang JT, Martinez HM. Determination of the secondary structures of proteins by circular dichroism and optical rotatory dispersion. Biochemistry. 1972;11:4120-4131.
19. Weiner SJ, Kollman PA, Nguyen DT. An all atom force field for simulations of proteins and nucleic acids. J Comp Chem. 1986;7:230-252.
20. Whitlow M, Teeter MM. An empirical examination of potential-energy minimization using the well-determined structure of the protein crambin. Am Chem Soc. 1986;108:7163-7172.
21. Keserü GM, Menyhárd DK. Role of proximal His93 in nitric oxide binding to metmyoglobin. Application of continuum solvation in Monte Carlo protein simulations. Biochemistry. 1999;38:6614-6622.
22. Daar IO, Maquat LE. Premature translation termination mediates triosephosphate isomerase mRNA degradation. Mol Cell Biol. 1988;8:802-813.
23. Lehotzky A, Telegdi M, Liliom K, Ovádi J. Interaction of phosphofructokinase with tubulin and microtubule: quantitative evaluation of the mutual effects. J Biol Chem. 1993;268:10888-10894.
24. Vértessy GB, Orosz F, Kovács J, Ovádi, J. Alternative binding of two sequential glycolytic enzymes to microtubules: molecular studies in phosphofructokinase/aldolase/microtubule system. J Biol Chem. 1997;272:25542-25546.
25. Minton AP, Will J. Effect of macromolecular crowding upon the structure and function of an enzyme: glyceraldehyde-3-phosphate dehydrogenase. Biochemistry. 1981;20:4821-4826.
26. Wasseem A, Steck TL. Protein associations with band 3 at cytoplasmic surface of human erythrocyte membrane. Methods Enzymol. 1989;173:513-519.
27. Volker KR, Knull HR. A glycolytic enzyme binding domain in tubulin. Arch Biochem Biophys. 1997;238:237-243.
28. Ovádi J, Vértessy BG, Kovács J, Wágner G, Liliom K., Orosz F. Interrelationship of cytoarchitecture and glucose metabolism. In: Wagner E, et al, eds. From Symbiosis to Eukaryotism. Geneva: Geneva University Press; 1999:517-532
29. Liliom K, Wágner G, Kovács J, Comin B, Cascante M, et al. Combined enhancement of microtubule assembly and glucose metabolism in neuronal systems in vitro. Decreased sensitivity to copper toxicity. Biochem Biophys Res Commun. 1999;264:605-610.
30. Arya R, Layton DM, Bellingham AJ. Hereditary red cell enzymopathies. Blood Rev. 1995;9:165-175.